120 related articles for article (PubMed ID: 34951103)
1. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
Liu L; Qin JF; Zuo MZ; Zhou Q
J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
[TBL] [Abstract][Full Text] [Related]
2. Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
Liu X; Liu B; Shang Y; Cao P; Hou J; Chen F; Zhang B; Fan Y; Tan K
Aging (Albany NY); 2022 Jan; 14(1):73-108. PubMed ID: 35017320
[TBL] [Abstract][Full Text] [Related]
3.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
5. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
[TBL] [Abstract][Full Text] [Related]
7. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
8. Computational analysis of TMPRSS2 expression in normal and SARS-CoV-2-infected human tissues.
Cao W; Feng Q; Wang X
Chem Biol Interact; 2021 Sep; 346():109583. PubMed ID: 34284028
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.
Hu RW; Liu C; Gong JP; Cao ZX
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2409-2414. PubMed ID: 33755980
[TBL] [Abstract][Full Text] [Related]
10. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.
Koch J; Uckeley ZM; Doldan P; Stanifer M; Boulant S; Lozach PY
EMBO J; 2021 Aug; 40(16):e107821. PubMed ID: 34159616
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
[TBL] [Abstract][Full Text] [Related]
12. Colorectal Cancer that Highly Express Both
Wang H; Yang J
Pathol Oncol Res; 2021; 27():612969. PubMed ID: 34257580
[TBL] [Abstract][Full Text] [Related]
13. Identification of key factors shaping integrated levels of ACE2 and TMPRSS2 expression in head and neck squamous cell carcinoma.
Zheng T; Yue P; Han T; Zhang K; Jiang Y; Wang S; Jiang L; Zhao B; Zhang X; Yan X
Front Biosci (Landmark Ed); 2021 Oct; 26(10):740-751. PubMed ID: 34719202
[No Abstract] [Full Text] [Related]
14. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.
Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G
J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.
Gkogkou E; Barnasas G; Vougas K; Trougakos IP
Redox Biol; 2020 Sep; 36():101615. PubMed ID: 32863223
[TBL] [Abstract][Full Text] [Related]
16. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
17. Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues.
Hu RW; Liu C; Gong JP; Cao ZX
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1724-1731. PubMed ID: 33629341
[TBL] [Abstract][Full Text] [Related]
18. Initial study on TMPRSS2 p.Val160Met genetic variant in COVID-19 patients.
Wulandari L; Hamidah B; Pakpahan C; Damayanti NS; Kurniati ND; Adiatmaja CO; Wigianita MR; Soedarsono ; Husada D; Tinduh D; Prakoeswa CRS; Endaryanto A; Puspaningsih NNT; Mori Y; Lusida MI; Shimizu K; Oceandy D
Hum Genomics; 2021 May; 15(1):29. PubMed ID: 34001248
[TBL] [Abstract][Full Text] [Related]
19. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
[TBL] [Abstract][Full Text] [Related]
20. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
